en · de · es · fr · pt
peptide-index.peptides6823.com › Data › Research And Regulatory Context — Hands-On Walkthrough

Research And Regulatory Context — Hands-On Walkthrough

By Editorial Desk · published 2026-03-24 · last reviewed 2026-04-15 · Data

The short version of lyophilized powder fits in a sentence. The long version — which is the one that helps — is below.

Reviewed 2026-04-15. Anything still debated is marked as such rather than presented as settled.

Research and Regulatory Context

Regulatory bodies have taken different approaches to AOD-9604. It is not approved as a prescription medicine by major agencies such as the U.S. Food and Drug Administration or the European Medicines Agency. In sport, the World Anti-Doping Agency prohibits peptide hormones, growth factors, and related substances, and AOD-9604 has been treated as a prohibited substance. These regulatory decisions reflect concerns about safety, efficacy, and potential misuse rather than proof of benefit.

Research on AOD-9604 also examines how the peptide is measured in biological samples. Analytical methods may include liquid chromatography coupled with mass spectrometry, immunoassays, or both. Detection can be challenging because the peptide is small and may be present at low concentrations. Published methods vary in sensitivity and specificity, so comparative interpretation requires attention to validation details. The presence of related hGH fragments can complicate identification in some matrices.

Handling, Analysis, and Quality Control

Quality varies among research-grade suppliers, so certificates of analysis and independent testing are important for verification. A typical certificate reports purity by HPLC, identity by mass spectrometry, appearance, and sometimes residual solvents or water content. AOD9604 is often sold as a research chemical not intended for human consumption, and labels can be inaccurate. Common misconceptions include treating the peptide as a form of growth hormone, assuming supplement status, or expecting approved-drug quality from unregulated products.

AOD9604 is commonly supplied as a white to off-white lyophilized powder. The powder is typically stored at -20 °C or below, protected from light and moisture, because peptides can degrade through oxidation, hydrolysis, or aggregation. If it is reconstituted for laboratory use, an appropriate aqueous buffer or solvent is chosen, and the solution is kept cold and handled to avoid repeated freeze-thaw cycles. These practices support stability but do not imply suitability for human use.

Aod-9604 at a glance

PropertyValueNotes
Regulatory statusNot approved as a medicineMajor agencies have not authorized it for therapeutic use.
Anti-doping statusProhibited in sportListed among peptide hormones and related substances.
Primary research areaMetabolic and body-composition effectsStudies often examine fat mass or lipid markers.
Human evidenceLimited and mixedPublic data do not establish clinical efficacy.
Analytical detectionLC-MS and immunoassaysMethods vary in sensitivity and validation.

Identity and Molecular Context

Researchers have studied the fragment in cell and animal models to understand its metabolic actions. Some experiments report effects on fat breakdown and fat storage pathways, but the underlying mechanism remains incompletely defined. AOD-9604 does not appear to stimulate the same broad growth hormone receptor signaling as full-length hGH. Whether its observed activities arise from direct receptor interactions or downstream metabolic changes is an open question. Results from different assays are not always consistent.

AOD-9604 is a synthetic peptide modeled on the C-terminal region of human growth hormone. It corresponds to residues 176-191 of the 191-amino-acid hGH sequence. The fragment is not the full hormone and lacks the receptor-binding region associated with growth and metabolic effects of hGH. Researchers developed it to isolate a specific portion of hGH for study. Its exact sequence and length are often stated in peptide catalogs and patents.

Related pages on this site

Regulation and Detection Context

Detection of AOD-9604 in biological samples relies on analytical techniques capable of distinguishing a small synthetic peptide from related endogenous sequences. Liquid chromatography coupled with tandem mass spectrometry is commonly used for confirmatory analysis. Sample preparation may involve immunoaffinity enrichment or solid-phase extraction to concentrate the peptide. Because the molecule is small and may be present at low concentrations, assay sensitivity and specificity are ongoing analytical challenges. Laboratories also validate methods against reference materials when available.

Regulatory interest in AOD-9604 increased after high-profile anti-doping cases involving peptide products. In some cases, the substance was supplied under alternative names or in compounded preparations, complicating traceability. Sports tribunals and anti-doping panels have discussed whether the peptide was explicitly banned at the time of use, leading to clarifications by the World Anti-Doping Agency. For consumers and researchers, the legal status can vary by jurisdiction, and products marketed as research chemicals may lack independent quality verification.

AOD-9604 is listed as a prohibited substance in sport by the World Anti-Doping Agency. It falls under the peptide hormones, growth factors, related substances, and mimetics class on the prohibited list. Anti-doping organizations treat its presence in an athlete's sample as an adverse finding unless a therapeutic use exemption applies. The prohibition reflects concerns about performance enhancement in competitive settings and the difficulty of distinguishing exogenous peptide use from endogenous hormone fragments.

Identity and Research Origin

Regulatory status varies by country. In the United States, AOD-9604 is not approved as a prescription drug. It is sometimes sold as a research chemical or dietary supplement, though such marketing may fall outside legal frameworks. The World Anti-Doping Agency prohibits its use in sport. Researchers must obtain it through legitimate suppliers and follow institutional rules. Its legal classification continues to evolve as authorities increasingly assess peptide products more broadly.

AOD-9604 is a synthetic peptide whose sequence matches the C-terminal fragment of human growth hormone, specifically residues 176 through 191. This region differs from the full hormone in its receptor interactions. The peptide is not a growth hormone secretagogue and does not bind the growth hormone receptor in the same manner. Researchers have examined it for effects on lipid metabolism, but its exact pharmacological profile remains an active area of study.

Background from the literature

=== Paul trap === A Paul trap (also known as a quadrupole ion trap) uses static direct current (DC) and radio frequency (RF) oscillating electric fields to trap ions. Paul traps are commonly used as components of mass spectrometers. Wolfgang Paul invented the Paul trap, hence its name. For this work he shared the 1989 Nobel Prize in Physics.

After 1956, the Sino-Soviet alliance began to break down. Mao had defended Stalin when Khrushchev criticized him in 1956 and treated the new Soviet leader as a superficial upstart, accusing him of having lost his revolutionary edge. For his part, Khrushchev, disturbed by Mao's glib attitude toward nuclear war, referred to the Chinese leader as a "lunatic on a throne". After this, Khrushchev made many desperate attempts to reconstitute the Sino-Soviet alliance, but Mao considered it useless and denied any proposal. The Chinese-Soviet animosity spilled out in an intra-communist propaganda war. Further on, the Soviets focused on a bitter rivalry with Mao's China for leadership of the global communist movement. Historian Lorenz M. Lüthi argues:

==== Methadone ==== Methadone has been used for opioid dependence since 1964, and is the most-studied of the pharmacological treatment options. It is a synthetic long-acting opioid, so it can replace multiple heroin uses by being taken once daily. It works by binding to the opioid receptors in the brain and spinal cord, activating them, reducing withdrawal symptoms and cravings while suppressing the "high" that other opioids can elicit. The decrease in withdrawal symptoms and cravings allow the user to slowly taper off the drug in a controlled manner, decreasing the likelihood of relapse, though some jurisdictions allow for indefinite maintenance on a dose at which the patient is comfortable. It is not accessible to all addicts. It is a regulated substance, and requires that each dose be picked up from a methadone clinic daily, though some jurisdictions allow take home doses. This can be inconvenient as some patients are unable to travel to a clinic, or wish to avoid the stigma associated with drug addiction. Treatment with methadone maintenance has been generally shown to significantly reduce mortality among opioid addicted populations. Its efficacy in reducing opioid use and positive treatment outcomes has been established, and is generally considered to be the "gold standard" of care for opiate addiction.

== Structure == Sericin is composed of 18 different amino acids, of which 32% is serine. The secondary structure is usually a random coil, but it can also be easily converted into a β-sheet conformation, via repeated moisture absorption and mechanical stretching. The serine hydrogen bonds give its glue-like quality. The genes encoding sericin proteins have been sequenced. Its C-terminal part contains many serine-rich repeats. Using gamma ray examination, it was determined that sericin fibers are composed typically of three layers, all with fibers running in different patterns of directionality. The innermost layer, typically is composed of longitudinally running fibers, the middle layer is composed of cross fiber directional patterned fibers, and the outer layer consists of fiber directional fibers. The overall structure can also vary based on temperature, whereas the lower the temperature, there were typically more β-sheet conformations than random amorphous coils. There are also three different types of sericin, which make up the layers found on top of the fibroin. Sericin A, which is insoluble in water, is the outermost layer, and contains approximately 17% nitrogen, along with amino acids such as serine, threonine, aspartic acid, and glycine. Sericin B, composed the middle layer and is nearly the same as sericin A, but also contains tryptophan. Sericin C is the innermost layer, the layer that comes closest to and is adjacent to fibroin. Also insoluble in water, sericin C can be separated from the fibroin via the addition of a hot, weak acid.

=== Solve rate === Although advances in forensic science and investigative techniques have helped solve many older cases, a substantial number of homicides remain unsolved each year in the United States, resulting in a growing backlog of cold cases.

Sources: en.wikipedia.org

Further detail

The existence of liquid water, and to a lesser extent its gaseous and solid forms, on Earth are vital to the existence of life on Earth as we know it. The Earth is located in the habitable zone of the Solar System; if it were slightly closer to or farther from the Sun (about 5%, or about 8 million kilometers), the conditions which allow the three forms to be present simultaneously would be far less likely to exist. Earth's size also plays a role: its gravity allows it to hold an atmosphere, including air moisture. Smaller planets like Mars have extremely thin or no atmospheres. Water vapor and other greenhouse gases in the atmosphere provide a temperature buffer (greenhouse effect) which helps maintain a relatively steady surface temperature when present in regular quantities. The state of water on a planet depends on ambient pressure, which is determined by the planet's gravity. If a planet is sufficiently massive, the water on it may be solid even at high temperatures, because of the high pressure caused by gravity, as it was observed on exoplanets Gliese 436 b and GJ 1214 b.

A mismatch between the circadian rhythm and the meals schedule, such as in circadian rhythm disorders, may increase insulin resistance. Insufficient sleep has been shown to cause insulin resistance, and also increases the risk of developing metabolic diseases such as type 2 diabetes and obesity.

In mammals, melatonin is critical for the regulation of sleep–wake cycles, or circadian rhythms. The establishment of regular melatonin levels in human infants occurs around the third month after birth, with peak concentrations observed between midnight and 8:00 am. It has been documented that melatonin production diminishes as a person ages. Additionally, a shift in the timing of melatonin secretion is observed during adolescence, resulting in delayed sleep and wake times, increasing their risk for delayed sleep phase disorder during this period. In adults, approximately 30 μg of melatonin is synthesized per day, nearly 80% of which occurs at night. The antioxidant properties of melatonin were first recognized in 1993. In vitro studies reveal that melatonin directly neutralizes various reactive oxygen species, including hydroxyl (OH•), superoxide (O2−•), and reactive nitrogen species such as nitric oxide (NO•). In plants, melatonin works synergistically with other antioxidants, enhancing the overall effectiveness of each antioxidant. This compound has been found to be twice as efficacious as vitamin E, a known potent lipophilic antioxidant, at scavenging peroxyl radicals. The promotion of antioxidant enzyme expression, such as superoxide dismutase, glutathione peroxidase, glutathione reductase, and catalase, is mediated through melatonin receptor-triggered signal transduction pathways.

== Interactions == Since bupropion is metabolized to hydroxybupropion by the enzyme CYP2B6, drug interactions with CYP2B6 inhibitors are possible: This includes such medications as paroxetine, sertraline, norfluoxetine (active metabolite of fluoxetine), diazepam, clopidogrel, and orphenadrine. The expected result is an increase in bupropion and a decrease in hydroxybupropion blood concentration. The reverse effect (decrease of bupropion and increase of hydroxybupropion) can be expected with CYP2B6 inducers such as carbamazepine, clotrimazole, rifampicin, ritonavir, St John's wort, and phenobarbital. Indeed, carbamazepine decreases exposure to bupropion by 90% and increases exposure to hydroxybupropion by 94%. Ritonavir, lopinavir/ritonavir, and efavirenz have been shown to decrease levels of bupropion and/or its metabolites. Ticlopidine and clopidogrel, both potent CYP2B6 inhibitors, have been found to considerably increase bupropion levels as well as decrease levels of its metabolite hydroxybupropion. Bupropion and its metabolites are inhibitors of CYP2D6, with hydroxybupropion responsible for most of the inhibition. Additionally, bupropion and its metabolites may decrease the expression of CYP2D6 in the liver. The end effect is a significant slowing of the clearance of other drugs metabolized by this enzyme. For instance, bupropion has been found to increase area-under-the-curve of desipramine, a CYP2D6 substrate, five-fold. Bupropion has also been found to increase levels of atomoxetine 5.1-fold, while decreasing the exposure to its main metabolite 1.5-fold.

The two substrates of this enzyme are (R)-pantolactone and oxidised nicotinamide adenine dinucleotide phosphate (NADP+). Its products are 2-dehydropantolactone, reduced NADPH, and a proton. This enzyme belongs to the family of oxidoreductases, specifically those acting on the CH-OH group of donor with NAD+ or NADP+ as acceptor. The systematic name of this enzyme class is (R)-pantolactone:NADP+ oxidoreductase (A-specific). Other names in common use include 2-oxopantoyl lactone reductase, ketopantoyl lactone reductase, 2-ketopantoyl lactone reductase, and 2-dehydropantoyl-lactone reductase (A-specific).

Sources: en.wikipedia.org

Background from the literature

=== Romanian Revolution === List of books about the Romanian Revolution List of films about the Romanian Revolution Ilie Verdeț, tried to take over power on 22 Dec 1989, but was pushed aside by I. Iliescu Videograms of a Revolution

==== Operation and distribution ==== All of Chipotle's restaurants are company-owned, rather than franchised. As of December 2012, 1,430 restaurants have since opened throughout the United States and Canada, with locations in 43 states, Ontario, British Columbia, and the District of Columbia. The field team are the employees who work closely with, but not directly within, specific restaurants. The field support system includes apprentice team leaders (step up from restaurateurs), team leaders or area managers, team directors, and regional directors (not atypical for them to oversee more than fifty locations). Because Chipotle does not franchise, all restaurants are owned and operated directly by the corporation itself. Thus, whenever Chipotle is in the process of launching a new location, the field team hires a new general manager and trains them at a current location so that they will be ready for the new location when it opens for business. The corporate office takes care of finding and funding new locations as well. In July 2023, the company announced it was testing a robot developed to cut the time to prepare avocados for guacamole in half amid an ongoing labor shortage. It was one of multiple chains incorporating automation into its operations at the time. It shows that the way food information is presented can significantly affect what people decide to eat, often shaping perceptions of healthfulness and encouraging certain purchasing behaviors.

Danith H. Ly is a Cambodian-American chemist and entrepreneur. He is a Professor of Chemistry at Carnegie Mellon University (CMU) and Founding Director of the Institute for Biomolecular Design and Discovery (IBD). His research focuses on nucleic acid chemistry, molecular recognition, and molecular engineering.

Germany's Federal Agency for Civic Education (German:Bundeszentrale für politische Bildung, or bpb) estimated that around 10,000 former athletes bear the physical and mental scars of years of drug abuse; one of them, Rica Reinisch, a triple Olympic champion and world record-setter at the 1980 Summer Olympics, has since had numerous miscarriages and recurring ovarian cysts. Two former Dynamo Berlin club doctors, Dieter Binus, chief of the national women's swim team from 1976 to 1980, and Bernd Pansold, in charge of the sports medicine center in East Berlin, were committed for trial for allegedly supplying 19 teenagers with illegal substances. Binus was sentenced in August, Pansold in December 1998 – both were found guilty of administering hormones to underage female athletes from 1975 to 1984. Virtually no East German athlete ever failed an official drugs test, though Stasi files show that many did produce failed tests at Kreischa, the Saxon laboratory (German:Zentrales Dopingkontroll-Labor des Sportmedizinischen Dienstes) that was at the time approved by the International Olympic Committee (IOC), now called the Institute of Doping Analysis and Sports Biochemistry (IDAS). In 2005, 15 years after the end of East Germany, the manufacturer of the drugs, Jenapharm, still found itself involved in numerous lawsuits from doping victims, being sued by almost 200 former athletes. Former Sport Club Dynamo athletes Daniela Hunger and Andrea Pollack publicly admitted to doping and accused their coaches for being responsible.

Sources: en.wikipedia.org

Frequently asked questions

Is AOD-9604 approved for medical use?

No. It is not approved as a therapeutic drug by major regulators. It is sold for research purposes in many settings, which is not the same as clinical approval.

Why is AOD-9604 banned in sports?

It is classified among peptide hormones and related substances that are prohibited in sport. The ban reflects anti-doping rules rather than a judgment that the peptide is effective for performance enhancement.

What do human studies show?

Human studies are limited and have not produced consistent evidence of meaningful clinical benefit. Some early trials examined metabolic endpoints, but larger confirmatory trials are generally lacking.

How is AOD9604 typically stored?

Lyophilized AOD9604 is generally kept at -20 °C or colder, desiccated, and protected from light. Reconstituted solutions are usually refrigerated and handled to minimize repeated freeze-thaw cycles. These are general laboratory handling practices, not instructions for human use.

Network